Biogen’s investors are growing restless.
Wednesday’s third-quarter earnings call checked most of the boxes for a successful report. The company raised its full-year guidance, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.